Skip to content
Home/Companies/Biotech/Avantium
AV

Avantium

Biotech·Netherlands·Exited 2017·Held 1yr

Avantium is a industrials company, headquartered in Netherlands.

Entry
2016
Hold
1yr
Exit
2017
Est. EV
–

Who owns Avantium?

Avantium was owned by Sofinnova Partners through Sofinnova Industrial Biotech (2018 vintage) from 2016 to 2017, exited via IPO. Across its history, Avantium has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Industrial Biotech · 2018 · VC
2 ownership periods · full history below

Key facts

HQNetherlands
SectorIndustrials
Key takeaways
  • ·Fully exited in 2017.
  • ·Average hold across 2 realized cycles: 3 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2017.
Co-invest · 2 holders · 2012 · 2017
Aster
AsterExited 2017
2012 · 2017 · Aster Capital I · 2010 · VC
IPO · to
MOIC
–
Sofinnova Partners
Sofinnova PartnersExited 2017
2016 · 2017 · Sofinnova Industrial Biotech · 2018 · VC
IPO
MOIC
–

More from Sofinnova Industrial Biotech

Other portfolio companies in the same fund.

Arzeda
Active
BiotechUS· 2022
IB WORKS I
Exited 2024
SoftwareFrance· 2022
Prometheus Materials
Active
BiotechUS· 2022
Novameat
Active
BiotechSpain· 2021
Qorium
Active
BiotechNetherlands· 2021
Verley (formerly Bon Vivant)
Active
BiotechFrance· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings